Search Within

Mark Weiss

Formats
  1. Meeting Abstract (38)
  2. Journal Article (35)
  3. Book Section (12)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (57)
  2. Center for Hematologic Malignancies (56)
  3. Hematologic Malignancies, Division of (56)
  4. Adult Leukemia (48)
  5. GSK Faculty (42)
  6. Hematologic Malignancies Research (42)

More Groups

People
  1. Peter Maslak (39)
  2. David Scheinberg (38)
  3. Nicole Lamanna (24)
  4. Joseph Jurcic (21)
  5. Ellin Berman (11)
  6. Mark Heaney (10)

More People

Years
  1. 2014 (1)
  2. 2010 (1)
  3. 2009 (4)
  4. 2008 (4)
  5. 2007 (5)
  6. 2006 (5)

More Years

Publications
  1. Blood (35)
  2. Journal of Clinical Oncology (8)
  3. Cancer (6)
  4. Leukemia (6)
  5. Cancer Management: A Multidisciplinary Approach. 10th ed (2)
  6. Cancer: Principles and Practice of Oncology. 5th ed (2)

More Publications

Publishers
  1. American Society of Hematology (35)
  2. American Society of Clinical Oncology (8)
  3. Nature Publishing Group (7)
  4. Wiley Blackwell (6)
  5. CMP Healthcare Media (5)
  6. Elsevier Inc. (5)

More Publishers

Results (86)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chronic lymphocytic leukemia
    Book Section

    Wierda, W. G.; Lamanna, N.; Cortes, J. E.; Weiss, M. A.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 10th ed (2007)

    Fulltext@MSK | Save
  • Soft-tissue sarcomas
    Book Section

    Pisters, P. W. T.; Weiss, M.; Maki, R.; Mann, G. N.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 10th ed (2007)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, rituximab, and mitoxantrone (PCRM): A new highly active regimen for patients with chronic lymphocytic leukemia (CLL) previously treated with PCR or FCR
    Meeting Abstract

    Lamanna, N.; Heaney, M. L.; Brentjens, R. J.; Jurcic, J. G.; Weiss, M. A.
    Blood (2007)

    Fulltext@MSK | Save
  • Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections
    Journal Article

    Horn, D. L.; Fishman, J. A.; Steinbach, W. J.; Anaissie, E. J.; Marr, K. A.; Olyaei, A. J.; Pfaller, M. A.; Weiss, M. A.; Webster, K. M.; Neofytos, D.
    Diagnostic Microbiology and Infectious Disease (2007)

    Fulltext@MSK | Save
  • Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemia
    Journal Article

    Byrd, J. C.; O'Brien, S.; Flinn, I. W.; Kipps, T. J.; Weiss, M.; Rai, K.; Lin, T. S.; Woodworth, J.; Wynne, D.; Reid, J.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • High leveI T cell suppression following purine analog therapy for patients with CLL correlates with important clinical benefit
    Meeting Abstract

    Landau, H.; Lamanna, N.; Hobart, S.; Weiss, M. A.
    Blood (2006)

    Fulltext@MSK | Save
  • In adult ALL, less is now more
    Journal Article

    Weiss, M. A.; Lamanna, N.
    Blood (2006)

    Fulltext@MSK | Save
  • Richter's syndrome: Factors to predict response and survival
    Journal Article

    Landau, H.; Weiss, M.
    American Journal of Oncology Review (2006)

    Fulltext@MSK | Save
  • Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Weiss, M. A.
    Seminars in Hematology (2006)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save